Integrated serum pharmacochemistry, 16S rDNA sequencing, and metabolomics to reveal the material basis and mechanism of Shouhui Tongbian capsule against diphenoxylate-induced slow transit constipation in rats
Open Access
- 11 October 2024
- journal article
- research article
- Published by Springer Nature in Chinese Medicine
- Vol. 19 (1) , 1-18
Abstract
Background: Slow transit constipation (STC) is highly prevalent and has rising incidence. Shouhui Tongbian capsule (SHTB) is a traditional Chinese Medicine formula with extensive and highly efficacious usage in STC treatment, however, its mechanism of action, especially the regulation of microbiome and lipid metabolites, remains unclear. Methods: After quality control of SHTB using LC‒MS to obtain its material basis, we tried to elucidate the cohesive modulatory network of SHTB against STC using hyphenated methods from microbiomics, lipidomics, mass spectrometry imaging (MSI) and molecular methods. Results: SHTB could repair intestinal barrier damage, reduce systemic inflammation and increase intestinal motility in a diphenoxylate-induced STC rat model. Based on 16S rDNA sequencing results, SHTB rehabilitated the abnormal changes in Alloprevotella, Coprococcus, Marvinbryantia, etc., which were associated with STC symptoms. Meanwhile, microbial functional prediction showed that lipid metabolism was improved with SHTB administration. The differential lipids, including fatty acids, lysophosphatidylcholine, phosphatidylcholine, sphingomyelin triglyceride and ceramide, that are closely related to STC disease and SHTB efficacy. Furthermore, SHTB significantly reversed the abnormal expression of these key target enzymes in colon samples, including CTP-phosphocholine cytidylyltransferase, CTP-phosphoethanolamine cytidylyltransferase, phosphatidic acid phosphatase, acid sphingomyelinase etc. Conclusions: Combined analysis demonstrated that SHTB reducing lipid accumulation and recovery of intestinal microbial homeostasis was the critical mechanism by which SHTB treats STC.Keywords
Funding Information
- CACMS Innovation fund (CI2021A05031)
- Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences (CI2021B017)
- National Natural Science Foundation of China (81370095)
- Key Research and Develop Program (Major Scientific and Technological Innovation Project) of Shandong Province (2021CXGC010508)
- Fundamental Research Funds for the Central Public Welfare Research Institutes (XTCX2023003)
This publication has 82 references indexed in Scilit:
- High fat diet–induced hyperlipidemia and tissue steatosis in rabbits through modulating ileal microbiotaApplied Microbiology and Biotechnology, 2022
- The Characteristics of Intestinal-Barrier Damage in Rats With IgA NephropathyThe American Journal of the Medical Sciences, 2020
- Aloe‐emodin: A review of its pharmacology, toxicity, and pharmacokineticsPhytotherapy Research, 2019
- Emodin: A Review of its Pharmacology, Toxicity and PharmacokineticsPhytotherapy Research, 2016
- Anthraquinones As Pharmacological Tools and DrugsMedicinal Research Reviews, 2016
- Constipation: Pathophysiology and Current Therapeutic Approaches2016
- A metabonomics study of Chinese miniature pigs with acute liver failure treated with transplantation of placental mesenchymal stem cellsMetabolomics, 2013
- Ceramide: a contributor to insulin resistance or an innocent bystander?Diabetologia, 2008
- Phospholipid biosynthesis in eukaryotes2008
- Sphingolipid breakdown products: anti-proliferative and tumor-suppressor lipidsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1993